Search Results

Point/Counterpoint: Is Interventional Oncology Ready to Stand on Its Own?

Interventional oncology sets aim on becoming the fourth pillar in the treatment of cancer.

With Michael C. Soulen, MD, FSIR, FCIRSE; Andreas Adam, MB, BS; and Lizbeth Kenny, MB, BS

Chief Medical Editor's Page

The Emergence of Renal Artery Stenting

By Barry T. Katzen, MD, Chief Medical Editor

Chief Medical Editor's Page.

The Emergence of Renal Artery Stenting

By Barry T. Katzen, MD, Chief Medical Editor

Options for In-Stent Restenosis in 2018

Capabilities and limitations of current technologies and available data.

By Brian G. DeRubertis, MD, FACS

EVAR: A Perspective From Across the Pond

Roger Greenhalgh, MD, discusses endovascular practice in the United Kingdom and the bearing that upcoming trial results will have on the future of EVAR.

An Interview with Barry T. Katzen, MD

EVT's Chief Interventional Radiologist and pioneer of live cases discusses their educational value and ethical challenges, and his recent awards.

By Barry T. Katzen, MD

An Interview with Jacques Busquet, MD

The president of ISES explains the society's impact on the worldwide endovascular community and the current state of this specialty in France.

Inventing Success

Interviews and insights from some of the biggest hitters of all time!

By Paul Gianneschi

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

An Interview With Lawrence A. Garcia, MD

With many treatment choices available for SFA disease, Dr. Garcia shares how he determines which therapy is right for each patient, as well as his current research endeavors.

Key Aortic Aneurysm Needs

By Andres Schanzer, MD, FACS, and Stéphan Haulon, MD, PhD

A Roundtable Discussion With Invatec

By Andrea Venturelli, CEO, CTO; Stefan Widensholer; and Jack Springer

Embolotherapy of Peripheral Arteriovenous Malformations

Advances in embolic agents and microcatheter techniques have allowed more successful treatment of this uncommon clinical entity.

By Wei Zhou, MD; Peter H. Lin, MD; Andres Eraso, MD; and Alan B. Lumsden, MD

Intraoperative Renal Artery Embolization With Concomitant Nephrectomy

A novel treatment approach for renal cell carcinoma, with potential benefits of cost saving and reduction of postinfarction syndrome.

By Peter H. Lin, MD; Ruth L. Bush, MD; Andres Eraso, MD; and Wei Zhou, MD

Fiber Optic RealShape Guidance in Endovascular Aortic Repair

Alternative guidance systems in endovascular surgery are poised to transform the way procedures are performed.

By Eric J. Finnesgard, MD, MS; Jessica P. Simons, MD, MPH; and Andres Schanzer, MD, FACS

Bead Technology: What’s New, What’s Next?

A review of mechanical properties and a discussion of available embolic particulates, recent advances for benign disease, novel concepts in the tumor microenvironment, and evolving use in liver cancer.

By Srinivasan Narayanan, MD, PhD; Andrea C. Cortes; and Rony Avritscher, MD